Real-world drug use in asthma, chronic obstructive pulmonary disease, rhinitis, cough, and cold in Finland from 1990 to 2021: Association with reduced disease burden.

Mattila, Tiina; Jormanainen, Vesa; Erhola, Marina; Vasankari, Tuula; Toppila-Salmi, Sanna; Herse, Fredrik; Leskelä, Riikka-Leena; Haahtela, Tari

Mattila, Tiina; Jormanainen, Vesa; Erhola, Marina; Vasankari, Tuula; Toppila-Salmi, Sanna; Herse, Fredrik; Leskelä, Riikka-Leena; Haahtela, Tari.

Afiliación

Mattila T; Department of Pulmonary Diseases, Heart and Lung Center, Helsinki University Hospital and Helsinki University, Helsinki, Finland.
Jormanainen V; Finnish Institute for Health and Welfare, Helsinki, Finland.
Erhola M; Finnish Institute for Health and Welfare, Helsinki, Finland.
Vasankari T; Ministry of Social Affairs and Health, Helsinki, Finland.
Toppila-Salmi S; The Wellbeing Services County of Pirkanmaa, Tampere, Finland.
Herse F; University of Turku, Turku, Finland.
Leskelä RL; Finnish Lung Health Association (FILHA), Helsinki, Finland.
Haahtela T; Department of Allergology, Skin and Allergy Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

Clin Transl Allergy ; 14(4): e12340, 2024 Apr.

Article en En | MEDLINE | ID: mdl-38558358

Palabras clave

COPD; asthma; health economics; public health; respiratory medications

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Clin Transl Allergy Año: 2024 Tipo del documento: Article País de afiliación: Finlandia Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google